Open Access · CC BY-NC-ND 4.0
16th Clinical Trials on Alzheimer's Disease (CTAD) Boston, MA (USA) October 24–27, 2023: Posters
The Journal of Prevention of Alzheimer's Disease · 2023-11 · 10 · 56-240
DOI: 10.14283/jpad.2022.130 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Prevention of Alzheimer's Disease, 2023-11. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2023). 16th Clinical Trials on Alzheimer's Disease (CTAD) Boston, MA (USA) October 24–27, 2023: Posters. The Journal of Prevention of Alzheimer's Disease, 10, 56-240. https://doi.org/10.14283/jpad.2022.130
Vancouver
16th Clinical Trials on Alzheimer's Disease (CTAD) Boston, MA (USA) October 24–27, 2023: Posters. The Journal of Prevention of Alzheimer's Disease. 2023;10:56-240. doi:10.14283/jpad.2022.130
BibTeX
@article{euvimed2023,
title = {16th Clinical Trials on Alzheimer's Disease (CTAD) Boston, MA (USA) October 24–27, 2023: Posters},
journal = {The Journal of Prevention of Alzheimer's Disease},
year = {2023},
volume = {10},
pages = {56--240},
doi = {10.14283/jpad.2022.130}
}
EUVIMED